Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status

This publication has 13 references indexed in Scilit:

• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth
  British Journal of Cancer, 1994
• Endovaginal Scanning of the Endometrium Compared to Cytology and Histology in Women with Postmenopausal Bleeding
  Gynecologic Oncology, 1993
• Tamoxifen for the Primary Prevention of Breast Cancer: A Review and Critique of the Concept and Trial
  Epidemiologic Reviews, 1993
• Breast Cancer
  New England Journal of Medicine, 1992
• Rapid growth of leiomyoma in patient receiving tamoxifen
  American Journal of Obstetrics and Gynecology, 1992
• Tamoxifen in premenopausal patients with metastatic breast cancer: a review.
  Journal of Clinical Oncology, 1991
• TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM
  The Lancet, 1989
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989
• Endometriosis developing during tamoxifen therapy
  American Journal of Obstetrics and Gynecology, 1988